Immediate Impact
1 from Science/Nature 62 standout
Citing Papers
Multiple sclerosis
2023 Standout
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
2022 Standout
Works of Peter A. Beatty being referenced
Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer
2003
Anterograde and Retrograde Amnesia in Patients With Chronic Progressive Multiple Sclerosis
1988
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Peter A. Beatty | 83 | 266 | 61 | 82 | 13 | 454 | |
| Luisa Pastò | 38 | 348 | 47 | 136 | 18 | 430 | |
| Thomas L. Auth | 36 | 341 | 30 | 145 | 13 | 508 | |
| Miklós Bánáti | 26 | 123 | 45 | 54 | 15 | 397 | |
| D. Farina | 62 | 319 | 38 | 96 | 14 | 424 | |
| E. Reggio | 40 | 170 | 92 | 48 | 11 | 423 | |
| G. Vacca | 78 | 297 | 68 | 126 | 16 | 470 | |
| Anthony P. Turel | 86 | 209 | 119 | 109 | 10 | 427 | |
| Nicola Bertolino | 34 | 114 | 84 | 71 | 24 | 378 | |
| H.A.M. van Diemen | 32 | 246 | 73 | 142 | 10 | 405 | |
| A. Garcı́a-Merino | 49 | 153 | 79 | 151 | 18 | 470 |
All Works
Loading papers...